Analysis of fibronectin, fibronectin receptor and interleukin-1 in patients with cirrhosis treated by the Yanggan Jieyu decoction

Figure 1 Serum FNR level in relation with plasma FN in 34 patients with chronic liver diseases (liver cirrhosis).

Figure 2 Serum levels of fibronectin in the hepatic fibrosis patients treated with the YGJY (Yanggan Jieyu) decoction.

Figure 3 Serum levels of the fibronectin receptor in the hepatic fibrosis patients treated with YGJY (Yanggan Jieyu) decoction.

Figure 4 Tumor necrosis factor released in hepatic fibrosis patients treated with the YGJY (Yanggan Jieyu) decoction.

Figure 5 Interleukin-1 release in hepatic fibrosis patients treated with the YGJY (Yanggan Jieyu) decoction.